Dividend Stocks

The Dividend Daily

Dividend stocks - News, notes, updates, and analysis, delivered fresh daily

Morgan Stanley Downgrades Colgate-Palmolive (CL)

Morgan Stanley reported on Friday that it has downgraded consumer products company, Colgate-Palmolive Company (CL).

The firm has lowered its rating on CL from “Overweight” to “Equal-weight,” and has removed its $121 price target.

An analyst from the firm commented, “we are downgrading CL to EW as we believe after recent multiple expansion (from 18x NTM PE in Dec to its current 20x NTM PE), CL’s premium valuation increasingly reflects LT advantages vs. peers. […] Colgate now trades at a 12% NTM P/E premium vs. large-cap peers, which is one standard deviation above its 10-year historical relative P/E average, after experiencing the highest YTD multiple expansion. We view this premium valuation as fair, and also believe topline risk vs. company guidance, while well understood, will likely limit further stock upside.”

Colgate-Palmolive shares were down -$1.36, or -1.19% during Friday morning trading. The stock has increased 18% in the past year.

The Bottom Line
Shares of Colgate-Palmolive Company (CL) have a 2.42% yield, based on Friday morning’s price of $112.51.

Colgate-Palmolive Company (CL) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

5 Rules of Winning Dividend Investing

FREE Dividend Stock Newsletter

Get the Dividend.com email newsletter to receive:

  • A free copy of our acclaimed report, 5 Rules of Winning Dividend Stock Investing
  • Free daily investing tips and picks from Dividend.com CEO Paul Rubillo
  • Tons of great market analysis and recommendations

Your Email

Free Dividend Newsletter

Get free dividend tips, analysis and updates straight to your inbox

Comments on this Article COMMENTS ON THIS ARTICLE

Comments are closed.

About This Article ABOUT THIS ARTICLE

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Disclaimer: Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.